Asston Pharmaceuticals IPO description – Asston Pharmaceuticals is engaged in the manufacturing and export of pharmaceutical formulations and nutraceutical products in domestic and various African markets. The company operates under the brand name “Asston.” Currently, it is involved in the manufacturing and marketing of tablets, capsules, oral liquids, external preparations (including ointments, creams, gels, and lotions), as well as oral powders (such as sachets and dry syrups).
As of 31 May 2025, Asston Pharmaceuticals caters to multiple corporate clients on a loan license and/or contract manufacturing basis. The company operates its production facility in Ambernath, Maharashtra, where it manufactures generic medicines in tablet form and nutraceutical products in tablet, syrup, and sachet forms.
Currently, Asston Pharmaceuticals holds over 150 registered trademarks for its pharmaceutical formulations. These products are distributed in various global markets, including South Africa and the West African region. As of 31 May 2025, the company has 46 permanent employees and 6 contractual employees across various departments.
Promoters of Asston Pharmaceuticals – Dr. Ashish Narayan Sakalkar, Saili Jayaram More, and Sachin Chandrakant Badakh
Table of Contents
Asston Pharma IPO Details
| Asston Pharmaceuticals IPO Dates | 9 – 11 July 2025 |
| Asston Pharma IPO Price | INR 115 – 123 per share |
| Fresh issue | 22,41,000 shares (INR 25.77 – 27.56 crore) |
| Offer For Sale | Nil |
| Total IPO size | 22,41,000 shares (INR 25.77 – 27.56 crore) |
| Minimum bid | 2,000 shares (INR 2,46,000) |
| Lot Size | 1,000 shares (INR 1,23,000) |
| Face Value | INR 10 per share |
| Retail Allocation | 35% |
| Listing On | BSE SME |
Asston Pharmaceuticals Financial Performance
| FY 2023 | FY 2024 | FY 2025 | 2M FY 2026 | |
| Revenue | 6.54 | 15.59 | 25.04 | 6.19 |
| Expenses | 5.78 | 14.02 | 19.91 | 4.44 |
| Net income | 1.06 | 1.36 | 4.33 | 1.32 |
Asston Pharmaceuticals Offer News
- Asston Pharmaceuticals RHP
- Asston Pharma Draft Prospectus
- ASBA IPO Forms
- Live IPO Subscription Status
- Highest SME IPO Subscription in 2024
Asston Pharmaceuticals Valuations & Margins
| FY 2023 | FY 2024 | FY 2025 | |
| EPS | 1.89 | 2.37 | 6.90 |
| PE ratio | – | – | 16.67 – 17.83 |
| RONW (%) | 53.21 | 21.28 | 40.36 |
| NAV | 3.55 | 10.19 | 17.09 |
| ROCE (%) | 56.08 | 34.29 | 51.25 |
| EBITDA (%) | 23.20 | 16.33 | 24.60 |
| Debt/Equity | 2.64 | 1.07 | 0.68 |
Asston Pharmaceuticals IPO GMP Today
| Date | Consolidated IPO GMP | Kostak | Subject to Sauda |
| 12 July 2025 | 33 | – | 25,000 |
| 11 July 2025 | 27 | – | 23,000 |
| 10 July 2025 | 20 | – | 15,000 |
| 9 July 2025 | 13 | – | 9,000 |
| 8 July 2025 | 10 | – | 7,500 |
| 7 July 2025 | 10 | – | 7,500 |
| 5 July 2025 | 10 | – | 7,500 |
Asston Pharmaceuticals IPO Subscription – Live Updates
| Category | QIB | NII | Individual | Total |
|---|---|---|---|---|
| Shares Offered | 4,25,000 | 3,22,000 | 7,46,000 | 14,93,000 |
| 11 Jul 2025 | 85.76 | 353.49 | 172.06 | 186.62 |
| 10 Jul 2025 | 4.47 | 20.02 | 16.66 | 13.92 |
| 9 Jul 2025 | 3.51 | 0.66 | 1.22 | 1.75 |
The market maker reservation portion of 1,13,000 shares and the anchor portion of 6,35,000 shares are not included in the above calculations.
Asston Pharmaceuticals IPO Allotment Status
Asston Pharmaceuticals IPO allotment status will be available on the Maashitla Securities website. Click on the Maashitla Securities IPO weblink to get allotment status.
Asston Pharmaceuticals IPO Dates & Listing Performance
| IPO Opening Date | 9 July 2025 |
| IPO Closing Date | 11 July 2025 |
| Finalization of Basis of Allotment | 14 July 2025 |
| Initiation of refunds | 15 July 2025 |
| Transfer of shares to demat accounts | 15 July 2025 |
| IPO Listing Date | 16 July 2025 |
| Opening Price on BSE SME | Coming soon |
| Closing Price on BSE SME | Coming soon |
Asston Pharmaceuticals Offer Lead Manager
SOBHAGYA CAPITAL OPTIONS PRIVATE LIMITED
C-4 to C-11, Gate No-01, Hosiery Complex,
Phase-II Extension, Noida 201305
Phone: +91 7836066001
Email: [email protected]
Website: www.sobhagyacap.com
Asston Pharmaceuticals Offer Registrar
MAASHITLA SECURITIES PRIVATE LIMITED
451, Krishna Apra Business Square,
Netaji Subhash Place, Pitampura, Delhi – 110034
Phone: 011-45121795
Email: [email protected]
Website: www.maashitla.com
Asston Pharmaceuticals Contact Details
ASSTON PHARMACEUTICALS LIMITED
4th Floor, Office No A-431, Balaji Bhavan,
Plot No 42A Sector-11, CBD Belapur, Navi Mumbai,
Thane – 400 614, Maharashtra, India
Phone: +91 22 49731411/+91 2249731419
E-mail: [email protected]
Website: www.asstonpharmaceuticals.com
IPO FAQs
What is the Asston Pharmaceuticals offer size?
Asston Pharmaceuticals offer size is INR 25.77 – 27.56 crores.
What is the Asston Pharmaceuticals offer price band?
Asston Pharmaceuticals public offer price is INR 115 – 123 per share.
What is the lot size of the Asston Pharmaceuticals IPO?
Asston Pharmaceuticals offer lot size is 1,000 shares.
What is Asston Pharmaceuticals IPO GMP today?
Asston Pharmaceuticals IPO GMP today is INR 33 per share.
What is the Asston Pharmaceuticals kostak rate today?
Asston Pharmaceuticals kostak rate today is INR NA per application.
What is Asston Pharmaceuticals IPO Subject to Sauda rate today?
Asston Pharmaceuticals Subject to Sauda rate today is INR 25,000 per application.